Raise your Query
Hi! Simply click below and type your query.
Our experts will reply you very soon.
Hi! Simply click below and type your query.
Our experts will reply you very soon.
| Brand Name | Cipla |
| Medicine Type | Allopathic |
| Form | Tablets |
| Dosage | As per Doctor Prescription |
| Click to view more | |
Preferred Buyer From
| Location | All Countries Except India |
Product Details
Abiraterone Is A CYP3A4 Substrate And Hence Should Not Be Administered In Patients Concurrently On Strong CYP3A4 Inhibitors Or Inducers.Likewise It Inhibits CYP1A2, CYP2C9 And CYP3A4 And Hence Should Not Be Given To Patients Concurrently Being Treated With Substrates Of Any Of These Enzymes That Have A Narrow Therapeutic Index.
